James Brumley
Contributor since: 2008
Latest Articles
Tech Stocks Killed The Market's Q4 Earnings; Healthcare And Financials Saved Them
Not Too Hot, Not Too Cold: Intercept Pharmaceuticals Is Right Where It Needs To Be
Ford Motor's Q4 Confirms Why It's Got A Profit Problem
Netflix Cash Bleed Reaches Record, And No Plausible End In Sight
Verizon's Big Bet? That It Doesn't Have To Make Big Bets
Beyond The Fog And Noise, Bausch Health Is On Track
Value Tough To Pin Down
FireEye May Be One Of The Market's Best-Kept Secrets... For Now
Take The S&P 500's Death Cross With A Huge Grain Of Salt
3 Reasons Foot Locker Kicked It Into High Gear
Don't Sweat The 'Death Cross' The Russell 2000 Just Made
Without iPhone Sales Data, Here's The Next Best Apple Yardstick
Amazon Isn't Just A Bet On A Premise Anymore
Seriously, The NASDAQ Composite's Bullishness Has Never Been This Top-Heavy
2 Reasons To Love Stocks, And One Not To Love Them Right Now
Here's The Biggest Thing Ford And GM Shareholders Should Worry About
Out With Sherwin-Williams, In With PPG Industries
Don't Believe The Hype Machine
OK, Maybe Amazon.com Can Earn Its Way Out Of Trouble After All
The Apple iPhone Just Got Lapped By Whom? Time To Rethink What Apple Is, And Isn't
The Real Netflix Problem In One Simple Chart
Here's Why Zynga Just 'Bazingad' The Doubters (And Will Continue Doing So)
The S&P 500 Passed The Tipping Point... Buckle Up
Whatever IBM Is Going To Do, It Must Do It Faster
Don't Let The General Electric Noise Distract You From The Bigger Picture
Let Sherwin-Williams Paint Your Portfolio Green
TFS Financial: The One That (Almost) Got Away
Become The Well-Rounded Investor You've Always Wanted To Be
Valeant Pharmaceuticals Finally Has The Missing Ingredient... Believers
The iShares U.S. Consumer Services ETF Is Ready To Roll
Gartner Becomes A Buy Again With A Redemptive Q1
CenturyLink Just Became A Very Interesting, Even If Speculative, Trade